Replies to post #13645 on Intellipharmaceutics International Inc. (IPCI)

[umiak]

"so never under-estimate the power of technical indicators"...Speaking of indicators, it is bullish for a stock to trade sideways. And while nothing is without risk, indicators do help support a higher swing trade range
as time goes by. Several other conditions can help, a low float and numerous possible catalysts, especially of the monetary nature. We know the company has redonculous big hitters over next few years and longs know that this is the short list:

During the three months ended August 31, 2015, the Company continued its focus on the development of its specialty drug product candidates Rexista™ Oxycodone XR and Regabatin™ XR. Considerable progress was made towards satisfying the requirements to file a New Drug Application ("NDA") for Rexista™ Oxycodone XR with the United States Food and Drug Administration ("FDA") and the Company plans to complete this filing in the first half of 2016. Regarding Regabatin™ XR, based on positive feedback and guidance from the FDA the Company submitted an Investigational New Drug Application ("IND") in August 2015.

We also know that a couple of events are nearer term, one being the CFO's willingness to hunt for shareholders in these small investor conferences across the US. An honest thought given to these events can picture who might attend. I contend they are at least speckled with investors that give serious thought to taking substantial long positions in companies that offer the potential for solid growth. Nano cap investors are their own breed.